Guidance

Breast screening: interval cancers and duty of candour toolkit

Guidance on the role of breast screening and symptomatic services in identifying interval cancer and giving results to patients.

• From: Public Health England
• Published: 11 December 2017
• Last updated: 18 February 2021 — See all updates

Documents

Interval cancers and applying duty of candour

Ref: PHE Gateway number 2017648

HTML

Breast screening: interval cancers explained infographic

Ref: PHE Gateway number 2017648

PDF, 104 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Breast screening: information sheet for women diagnosed with breast cancer

HTML

Breast screening: information sheet for women diagnosed with breast cancer

Ref: PHE Gateway number 2017648

PDF, 77.7 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Breast screening: information for screening and symptomatic services informing women about disclosure of audit and duty of candour

PDF, 154 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

These documents are a toolkit of guidance on interval breast cancers for healthcare professionals to use when applying the duty of candour.

The toolkit includes:

• guidance on interval cancers and applying duty of candour
• an HTML and PDF version of an information leaflet for women about being diagnosed with breast cancer between screening appointments (the PDF version is available for trusts wishing to print the document for a patient)
• a PDF format infographic about interval cancers (to print out as required)
• a flowchart showing the application of duty of candour

Contact the PHE Screening helpdesk with any queries about this publication, making sure you include its full title.

Published 11 December 2017
Last updated 18 February 2021 + show all updates

1. 18 February 2021

   Added accessible version of 'Breast screening: information sheet for women diagnosed with breast cancer'.

2. 24 November 2020

   Added section: Dates to apply duty of candour.

3. 26 March 2018

   Added flowchart with information for screening and symptomatic services informing women about disclosure of audit and duty of candour.

4. 11 December 2017

   First published.